Skip to main content

Premature Labor News (Page 5)

Higher Maternal Death Rates Among Black Women Tied to Racism, Sexism, UN Says

THURSDAY, July 13, 2023 – Black women are more likely to die during or soon after childbirth due to systemic racism and sexism in the medical system, not genetics or lifestyle, according to the...

Monkey Study Suggests Hazards of Marijuana Use During Pregnancy

TUESDAY, July 11, 2023 – Marijuana use during pregnancy may impact the baby’s brain development and long-term health, according to new research with monkeys. THC (delta-9-tetrahydrocannabinol) – t...

AMAG Pharmaceuticals Announces FDA Approval of Makena (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women

WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) approved the Makena® subcutaneous au...

FDA Medwatch Alert: Magnesium Sulfate: Drug Safety Communication - Recommendation Against Prolonged Use in Pre-term Labor

ISSUE: FDA is advising health care professionals against using magnesium sulfate injection for more than 5-7 days to stop pre-term labor in pregnant women. Administration of magnesium sulfate...

FDA Approves Makena to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

progesterone, nifedipine